F2RL1 and esophageal cancer: In addition, PAR2 activation promotes the reversal of epidermal growth factor (EGF) and the release of TGF-α, induces tumor angiogenesis, and mediates the proliferation of gastric, colon, and esophageal cancer cells [36].